Precision BioSciences, Inc. - Common Stock (DTIL)
Frequently Asked Questions About Precision BioSciences, Inc. - Common Stock (DTIL)
Are there any educational resources provided by Precision BioSciences?
Yes, Precision BioSciences provides educational resources through its website, including information about gene editing technology, research updates, and insights into the clinical applications of their therapies.
Does Precision BioSciences have any partnerships?
Yes, Precision BioSciences has entered into several strategic partnerships with leading pharmaceutical companies and research institutions to enhance its research efforts and broaden the applications of its technologies.
Has Precision BioSciences received any funding?
Yes, Precision BioSciences has successfully raised substantial funding through various financing rounds, grants, and strategic partnerships to support its research and development activities.
How can investors get involved with Precision BioSciences?
Investors can engage with Precision BioSciences by purchasing shares through the Nasdaq stock exchange under the symbol 'DTIL', attending investor relations events, and keeping informed through company announcements and reports.
How does Precision BioSciences ensure patient safety?
Precision BioSciences places a strong emphasis on patient safety by conducting rigorous preclinical studies, adhering to ethical research practices, and following regulatory guidelines throughout the development process.
How does Precision BioSciences' technology differ from CRISPR?
While both Precision BioSciences' ARCUS technology and CRISPR are gene editing methods, ARCUS utilizes engineered nucleases that provide higher specificity and reduced off-target effects compared to traditional CRISPR approaches.
Is Precision BioSciences publicly traded?
Yes, Precision BioSciences is publicly traded on the Nasdaq stock exchange under the ticker symbol 'DTIL', allowing investors to participate in its growth potential.
What are some key milestones in Precision BioSciences' history?
Some key milestones in Precision BioSciences' history include the development of their ARCUS platform, successful clinical trials for their therapies, and significant partnerships that have advanced their research efforts.
What are the future plans for Precision BioSciences?
Going forward, Precision BioSciences aims to advance its clinical programs, expand its partnership network, and continue to innovate within the gene editing landscape to maximize the potential of its therapies.
What does Precision BioSciences, Inc. do?
Precision BioSciences is a biotechnology company that primarily focuses on gene editing and gene therapy. They utilize proprietary technology to develop transformative therapies for a range of diseases, particularly genetic disorders and cancer.
What is Precision BioSciences' approach to gene editing?
Precision BioSciences employs a unique, precision-focused approach to gene editing, aiming to create safe, effective, and efficient modifications to the genome using its ARCUS platform, reducing off-target effects.
What is the core technology used by Precision BioSciences?
The core technology utilized by Precision BioSciences is their proprietary ARCUS genome editing platform. ARCUS is designed to precisely edit DNA through a novel approach that allows for highly targeted, efficient, and safe modifications.
What is the goal of Precision BioSciences' research initiatives?
The primary goal of Precision BioSciences' research initiatives is to create innovative therapies that provide significant clinical benefit by correcting genetic defects, treating complex diseases, and improving patient outcomes.
What is the significance of the name 'Precision' in Precision BioSciences?
'Precision' in Precision BioSciences signifies the company's commitment to targeted and accurate gene editing, aiming to minimize unintended effects while maximizing therapeutic outcomes.
What is the vision of Precision BioSciences?
Precision BioSciences envisions a future where precision gene editing can transform the treatment landscape for genetic disorders and cancer, empowering patients through effective and personalized therapies.
What regulatory approvals does Precision BioSciences seek?
Precision BioSciences seeks regulatory approvals from agencies such as the U.S. Food and Drug Administration (FDA) for its investigational therapies before they can move into clinical use and commercialization.
What types of clinical trials is Precision BioSciences involved in?
Precision BioSciences is involved in various phases of clinical trials aimed at evaluating the safety and efficacy of its gene editing therapies in patients with genetic disorders and various cancers.
What types of diseases does Precision BioSciences target?
Precision BioSciences focuses on developing therapies for various conditions, including genetic diseases, cancer, and infectious diseases, targeting areas where traditional treatments may fall short.
When was Precision BioSciences founded?
Precision BioSciences was founded in 2006, and since its inception, it has been dedicated to pioneering advancements in gene editing technologies.
Where is Precision BioSciences headquartered?
Precision BioSciences is headquartered in Durham, North Carolina, which places it within a vibrant biotech ecosystem known for its innovative research and development.
What is the current price of Precision BioSciences, Inc. - Common Stock?
The current price of Precision BioSciences, Inc. - Common Stock is 4.710
When was Precision BioSciences, Inc. - Common Stock last traded?
The last trade of Precision BioSciences, Inc. - Common Stock was at 4:00 pm EDT on April 3rd, 2025
What is the market capitalization of Precision BioSciences, Inc. - Common Stock?
The market capitalization of Precision BioSciences, Inc. - Common Stock is 535.97M
How many shares of Precision BioSciences, Inc. - Common Stock are outstanding?
Precision BioSciences, Inc. - Common Stock has 113.79M shares outstanding.